R&D
🇺🇸 FDA Page 9FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Gain critical insights into global pharmaceutical R&D trends, drug discovery pipelines, and clinical trial advancements. Drive your pharma strategy.
Showing 97–108 of 117 articles
Inventiva Bolsters Executive Team Ahead of Lanifibranor Phase 3 Data
FDA Cracks Down on Illegal Tobacco Products Disguised as Everyday Items
Surgeon General's Warning on Children's Screen Time: A Pharma Industry Analysis
Immunovant's IMVT-1402 Shows Blockbuster Potential in Autoimmune Disease; Wave Life Sciences Advances RNA Editing
Eli Lilly Dominates Pharma R&D Performance Rankings, Setting New Benchmarks
UCB's Bimzelx Triumphs Over AbbVie's Skyrizi in Psoriatic Arthritis
How to Use openFDA and FAERS Data Without Misreading Safety Signals
Formycon AG Geschäftsbericht 2025: Key Insights and Implications
Akeso and Summit Drug Shows Promise in Lung Cancer Trial
Verge Rebrands AI Drug Discovery After Trial Setback
Kailera’s Three-Pronged Obesity Shot Shows Promise in Early Trial
STAT+: Experimental Parkinson's Drug Fails Key Trial - Insights